GLAS CIK: 1848731

Glass House Brands Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
15.8
FY22:
20.7
FY23:
81.0
FY24:
97.4
FY25:
77.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−36.2
FY22:
−56.4
FY23:
−49.5
FY24:
5.74
FY25:
−16.5
(positive)
Change from FY21 to FY25
millions USD
FY21:
−41.3
FY22:
−37.3
FY23:
−88.1
FY24:
11.2
FY25:
−17.0
(positive)
Change from FY21 to FY25
millions USD
FY21:
−43.1
FY22:
−32.9
FY23:
−98.3
FY24:
0.52
FY25:
−29.7

All amounts in millions USD Data source:SEC EDGAR